Brainstorm Cell Therapeutics (BCLI) Earnings
|
Expand Research on BCLI
| Next EPS Date | 8/17/26 | EPS Growth Rate | +62.3% |
|---|---|---|---|
| Average EPS % Beat Rate | -1,100.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.4% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/17/26  |
Q226 | N/A | -$0.29 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/14/25 | Q325 | -$0.19 | $0.00 | -$0.19 | N/A | N/A | N/A |  | | Details | |
| 8/14/25 |
Q225 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/25 | Q225 | -$0.77 | $0.00 | -$0.77 | N/A | N/A | N/A | | | Details | |
| 5/15/25 | Q125 | -$0.45 | $0.00 | -$0.45 | N/A | N/A | N/A | | | Details | |
| 11/14/24 |
Q324 | -$1.80 | -$0.04 | -$1.76 | N/A | N/A | N/A | | | Details | |
| 8/14/24 | Q224 | -$0.04 | -$0.07 | +$0.03 | N/A | N/A | N/A | | | Details | |
| 5/13/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
